Discovery Life Sciences Acquires ReachBio Research Labs
"We share Discovery's passion for science and believe that combining our expertise in cell-based assays and drug screening with Discovery's broad multi-omics capabilities will enable us to provide a broader and more strategic range of services to clients in the pharmaceutical industry."
- Emer Clarke, CSO ReachBio
Our use of primary cell systems allows us to provide our clients with more predictable and clinically-relevant assays.
Extensive knowledge allows us to provide high quality primary cells from bone marrow and peripheral blood.
The latest news, updates, and information from our lab in Seattle, WA.
Find us on the Science Exchange website
Impact of Monoclonal Antibody (MoAb), Payload and Linker ...
Reliable and Predictive In Vitro Assays for Myelotoxicity ...
Looking for more? View all posts